KLP Kapitalforvaltning AS Makes New $939,000 Investment in Phibro Animal Health Co. (NASDAQ:PAHC)

KLP Kapitalforvaltning AS purchased a new stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 44,700 shares of the company's stock, valued at approximately $939,000. KLP Kapitalforvaltning AS owned approximately 0.11% of Phibro Animal Health as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of PAHC. Sei Investments Co. raised its holdings in shares of Phibro Animal Health by 3.5% during the fourth quarter. Sei Investments Co. now owns 161,667 shares of the company's stock valued at $3,395,000 after acquiring an additional 5,436 shares during the last quarter. American Century Companies Inc. raised its stake in Phibro Animal Health by 18.0% in the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock valued at $13,348,000 after purchasing an additional 96,787 shares during the last quarter. Quantbot Technologies LP raised its stake in Phibro Animal Health by 65.1% in the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock valued at $107,000 after purchasing an additional 2,018 shares during the last quarter. Summit Global Investments purchased a new position in Phibro Animal Health in the 4th quarter valued at $571,000. Finally, Semanteon Capital Management LP acquired a new stake in Phibro Animal Health during the 4th quarter worth $417,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Stock Down 0.3 %

Shares of Phibro Animal Health stock traded down $0.07 during trading hours on Wednesday, hitting $21.90. The company had a trading volume of 142,342 shares, compared to its average volume of 184,934. The company's 50-day moving average is $22.80 and its two-hundred day moving average is $22.69. Phibro Animal Health Co. has a twelve month low of $12.30 and a twelve month high of $26.55. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The company has a market cap of $887.02 million, a P/E ratio of 45.63, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58.

Remove Ads

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 2.19%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health's dividend payout ratio (DPR) is 100.00%.

Analyst Ratings Changes

Several equities research analysts recently commented on PAHC shares. Morgan Stanley increased their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. StockNews.com downgraded Phibro Animal Health from a "buy" rating to a "hold" rating in a research note on Tuesday, March 25th. Finally, Barclays upped their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a report on Monday, February 10th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $21.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.